Nose-to-Brain Delivery of Acyl-Ghrelin Peptide Gold Nanoconjugates for Treatment of Neurodegenerative Diseases.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Nose-to-Brain Delivery of Acyl-Ghrelin Peptide Gold Nanoconjugates for Treatment of Neurodegenerative Diseases.
- Published In:
- Small (Weinheim an der Bergstrasse, Germany), 21(36), e04517 (2025)
- Authors:
- Han, Shunping, Utami, Rifka N, Qin, Yue, Liam-Or, Revadee, Sreedharan, Jemeen, Davies, Jeffrey S, Al-Jamal, Khuloud T
- Database ID:
- RPEP-11272
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-11272APA
Han, Shunping; Utami, Rifka N; Qin, Yue; Liam-Or, Revadee; Sreedharan, Jemeen; Davies, Jeffrey S; Al-Jamal, Khuloud T. (2025). Nose-to-Brain Delivery of Acyl-Ghrelin Peptide Gold Nanoconjugates for Treatment of Neurodegenerative Diseases.. Small (Weinheim an der Bergstrasse, Germany), 21(36), e04517. https://doi.org/10.1002/smll.202504517
MLA
Han, Shunping, et al. "Nose-to-Brain Delivery of Acyl-Ghrelin Peptide Gold Nanoconjugates for Treatment of Neurodegenerative Diseases.." Small (Weinheim an der Bergstrasse, 2025. https://doi.org/10.1002/smll.202504517
RethinkPeptides
RethinkPeptides Research Database. "Nose-to-Brain Delivery of Acyl-Ghrelin Peptide Gold Nanoconj..." RPEP-11272. Retrieved from https://rethinkpeptides.com/research/han-2025-nosetobrain-delivery-of-acylghrelin
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.